Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 24 (Search time: 0.028 seconds).
Issue DateTitleAuthor(s)
2013EGFR GENOTYPING AND EPIDEMIOLOGY, CLINICAL AND PATHOLOGICAL FEATURES IN 191 PATIENTS WITH METASTATIC PULMONARY ADENOCARCINOMA IN SAO PAULO - BRAZIL.CASTRO JR., Gilberto; TAKAHASHI, Tiago K.; CAIRES-LIMA, Rafael; PROTASIO, Bruno M.; MAIA, Manuel C. D. F.; SOARES, Ibere C.; ROITBERG, Felipe S. R.; MARINI, Andrea M.; MARTINS, Renata E.; TAKAGAKI, Teresa Y.; ARAUJO, Pedro H. X. N.; TERRA, Ricardo M.; SHIANG, Christina; SIQUEIRA, Sheila A. C.; MELLO, Evandro S.; ALVES, Venancio A.; HOFF, Paulo M.
2019CANOPY-1: Phase 3 Study of Canakinumab/Placebo plus Pembrolizumab plus Platinum-Chemotherapy in Untreated Stage IIIB-IV NSCLC PtsFELIP, E.; CASTRO, G.; GREYSTOKE, A.; SOLOMON, B.; TAN, D.; PASSOS, V.; DEUDON, S.; LOUVEAU, A.; JOHNSON, B.
2019Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer in Brazil (GBOT 0118/LACOG 0418)MASCARENHAS, E.; GELATTI, A.; LIMA, V. De; ARAUJO, L. H.; BALDOTTO, C.; MATHIAS, C.; ZUKIN, M.; WERUTSKY, G.; FILGO, P. R. Nunes; GOMES, R.; CASTRO, G.
2012EGFR ACTIVATING MUTATIONS IN NSCLC: IMPORTANCE OF ROUTINE TESTINGTAKAHASHI, Tiago K.; SOARES, Ibere C.; MARINI, Andrea M.; MAK, Milena P.; TEIXEIRA, Carlos H.; ROITBERG, Felipe S. R.; TAKAGAKI, Teresa Y.; MARTINS, Renata E.; MESQUITA, Cristiane; HOFF, Paulo M. G.; CASTRO JR., Gilberto
2019Immune Profiling Data and Mutational Status Improves Prediction of Risk of Death in Non-Small Cell Lung CarcinomaPARRA, E.; JANG, M.; MACHADO-RUGOLO, J.; FARHAT, C.; NAGAI, M.; TAKAGAKI, T.; TERRA, R.; FABRO, A.; CAPELOZZI, V.
2019CANOPY-1: Phase 3 Study of Canakinumab/Placebo plus Pembrolizumab plus PlatinumChemotherapy in Untreated Stage IIIB-IV NSCLC PatientsJOHNSON, B. E.; CASTRO, G. D.; GREYSTOKE, A.; SOLOMON, B.; TAN, D. S. W.; PASSOS, V.; DEUDON, S.; LOUVEAU, A. L.; FELIP, E.
2018Association of Functional Polymorphism in CTLA-4 Gene with Survival in Non-Small Cell Lung Cancer: A Brazilian StudyMACHADO-RUGOLO, J.; FABRO, A.; CUENTAS, E.; SA, V. De; RAINHO, C.; NAGAI, M.; CAPELOZZI, V.; BALANCIN, M.
2012ERCC1 AND BETA-TUBULIN III IN ADVANCED NSCLC PATIENTS TREATED WITH CISPLATIN-VINORELBINECASTRO JR., G. de; VICTOR, C. R.; BIGATON, F. J.; TAKAHASHI, T. K.; FEHER, O.; SABER, A. M. Ab'; TAKAGAKI, T. Y.; SIQUEIRA, S. A. C.; CHAMMAS, R.; HOFF, P. M. G.
2020The CANOPY Program: Three Phase 3 Studies Evaluating Canakinumab in Patients with Non-Small Cell Lung Cancer (NSCLC)GARON, E. B.; ARDIZZONI, A.; BARLESI, F.; CHO, B. C.; CASTRO, G. De; FELIP, E.; GOTO, Y.; GREYSTOKE, A.; LU, S.; LIM, D. W. -T.; RECK, M.; SOLOMON, B. J.; SPIGEL, D. R.; TAN, D. S. W.; THOMAS, M.; YANG, J. C. -H.; JOHNSON, B. E.
2012REFERRAL OF LUNG CANCER PATIENTS TO SPECIALIZED CLINICAL ONCOLOGY CARE: INSTITUTO DO CANCER DO ESTADO DE SAO PAULO 2010-2011CAIRES-LIMA, Rafael; TAKAHASHI, Tiago K.; MAK, Milena P.; ROITBERG, Felipe S. R.; TEIXEIRA, Carlos H. A.; MESQUITA, Cristiane S.; MARINI, Andrea M.; MARTINS, Renata E.; TAKAGAKI, Tereza Y.; ARAUJO, Pedro N.; FEHER, Olavo; HOFF, Paulo M.; CASTRO JR., Gilberto De